KALV KalVista Pharma Total Asset Value of Company
The current chart of total asset value for KalVista Pharmaceuticals (KALV) on the GURU.Markets platform stands at 207.86. High barriers to entry in the sector are driven by colossal costs for multi-year testing and stringent regulatory oversight. KalVista Pharmaceuticals (KALV) is accelerating the search for new molecules by integrating AI and automation into bio-screening. Management is currently focusing on bringing its core product to market, leveraging the credibility gained from successful trials.
Analytical breakdowns and data insights for company KalVista Pharmaceuticals Inc (KALV)
- share price and consensus valuation forecast:
- market capitalization data:
- issuer book value statistics:
- debt burden and liquidity indicators:
All Debt to Shareholders' Equity Ratio KalVista Pharmaceuticals|KALV - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio KalVista Corp|KALV - Company Aggregate Debts|Debts to Book Capitalization KalVista Corp|KALV - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings KalVista Pharmaceuticals|Interim Coverage Ratio kalvista.com
- net income and valuation multiples indicators:
Fundamental valuation:KalVista Pharmaceuticals
This metric is calculated inversely via ROA, making it sensitive to any changes in return on assets and resource efficiency. Analyzing the current level of total assets on GURU.Markets allows for an assessment of KalVista Pharmaceuticals (KALV) resilience to geopolitical risks that could limit international cooperation and access to biomaterials, transforming local dips on the chart into a signal of hidden opportunities or fundamental threats.
Key competitors
ARGX (argenx.com) - Aggregate Company Assets|Aggregate Company Assets BioNTech|Abivax - Total Asset Value of Company|Company Total Assets ADMA|PTGX (Protagonist Corp) - Aggregate Asset Value|Company Total Assets IMVT (Immunovant, Inc.)|Company Total Assets kiniksa.com KNSA|GRFS - Aggregate Company Assets|Aggregate Asset Value ADPT (Adaptive Biotech)|Celldex (CLDX) - Aggregate Company Assets|Cumulative Company Assets Aurinia Corp|BCRX (BioCryst) - Company Total Assets|Company Total Assets veratx.com|Cumulative Company Assets DNTH (Dianthus Therapeutics, Inc.)|PHVS (Pharvaris NV) - Aggregate Asset Value|Company Total Assets ABCL (abcellera.com)|Company Total Asset Base Tourmaline (TRML)|PGEN - Aggregate Company Assets|pharming.com (PHAR) - Cumulative Company Assets|Nektar Therapeutics Inc. (NKTR) - Aggregate Company Assets|Cumulative Company Assets Upstream Bio, Inc.|Cumulative Company Assets ZBIO|Company Total Assets Immunome Bio|Aggregate Company Assets Gossamer Bio, Inc. (GOSS)|septerna.com - Total Business Assets|Company Total Assets PVLA (Pieris Pharmaceuticals, Inc.)|Savara Inc (SVRA) - Company Assets|RIGL - Aggregate Company Assets|ANAB - Company Total Assets|ATXS: Company Total Assets|engene.com (ENGN) - Company Total Assets|Aggregate Company Assets RAPT Therapeutics|Aggregate Company Assets JBIO|Cumulative Company Assets ACRS (Aclaris)|Aggregate Company Assets KYTX (Kyverna Therapeutics, Inc)|Company Total Assets TLSA (Tiziana Life Sciences)|Company Total Asset Base cabalettabio.com (CABA)|VTYX - Aggregate Company Assets|Company Total Asset Base Theratechnologies, Inc. THTX|AVTX (Avalo Therapeutics Inc.) - Cumulative Company Assets|ELDN: Aggregate Business Assets|AGEN (Agenus) - Company Total Assets|Company Total Assets climbbio.com|Cumulative Company Assets ZURA (Zura Bio)|ATYR (aTyr Pharma Inc) - Aggregate Asset Value|Aggregate Company Assets Adagene Inc. ADAG|IMA (ImageneBio) - Total Asset Value of Company|Shattuck Therapeutics - Company Total Assets|Aggregate Asset Value EQ (Equillium, Inc.)|CNTB: Company Total Assets|Immunic (IMUX) - Company Total Assets|Aggregate Company Assets Atara Biotherapeutics, Inc.|IFRX: Aggregate Asset Value|Aggregate Company Assets X4 Pharmaceuticals (XFOR)|Cumulative Company Assets adicetbio.com ACET|Company Total Assets CELU (Celularity)|Company Total Assets INmune Bio Inc INMB|Barinthus Bio - Company Total Assets|Kezar Life Sciences Inc (KZR) - Cumulative Company Assets|SABS: Company Total Assets|Company Assets akaritx.com (AKTX)|Cumulative Company Assets ENLV|Company Total Assets Q32 Bio Corp|Cumulative Company Assets GOVX (GeoVax Labs Inc)|Aggregate Business Assets EDSA|Company Total Assets IBIO (iBio, Inc.)|Company Total Asset Base Carisma Therapeutics Inc (CARM)|XTL Biopharmaceuticals Ltd. - Company Total Assets|Bolt Biotherapeutics (BOLT) - Cumulative Company Assets|HCWB: Company Total Assets|Aptevo Therapeutics Inc. (APVO) - Company Total Assets|Aggregate Company Assets AIM ImmunoTech Inc.|Aggregate Company Assets ADTX|Aggregate Company Assets GRI Bio (GRI)|Company Total Asset Base XORTX Therapeutics Inc|Aggregate Company Assets ReShape Lifesciences HIND|Company Total Assets Revelation Biosciences Corp REVB|Indaptus Therapeutics - Company Total Assets|SCNI - Company Total Assets|calcimedica.com (CALI) - Aggregate Company Assets|AFMD (Affimed N.V.) - Aggregate Company Assets|Cumulative Company Assets ALLK|Aggregate Company Assets HOOK|Aggregate Company Assets IGM Biosciences, Inc. (IGMS)|ITOS: Total Asset Value of Company|Company Total Assets OCEA (Ocean Biomedical)|Aggregate Asset Value TCBP|Third Harmonic Bio, Inc - Company Total Assets